Ozempic and Wegovy Show Promise in Reducing Migraine Severity and Osteoarthritis Damage

Recent studies indicate that GLP-1 drugs like Ozempic and Wegovy may have dual benefits beyond weight management. They could potentially reduce migraine symptom severity and reverse osteoarthritis damage, showing promise for broader therapeutic applications. Researchers will need to conduct more extensive trials to confirm these findings and assess long-term safety.